HospitalNews

HCG Takes 1st Step Towards Creating Outcome Based Scoring for Clinicians, Institutes

Stanford's Dr Jayanta Bhattacharya to collaborate with HCG to create India specific Algorithms

Bangalore, 2 July, 2019: HealthCare Global Enterprises Ltd. (HCG), the largest provider of cancer care in India, has said that it will collaborate with Dr Jayanta Bhattacharya, MD, PhD, Director, Center on Demography and Economics of Health and Aging, Stanford University, to create algorithms for scoring clinicians and institutes based on patient outcomes. This will help HCG manage its resources wisely and incentivize meaningful use of resources and good clinical outcomes.

At present there is no way to measure the performance of a clinician or an institute in India. There has been growing discontent among the patients regarding care provided at hospitals and the number of medical negligence cases are on the rise. A standard transparent performance score will not only bring back the trust in doctor-patient relationship but it will also promote ethical practice and quality of care, said Dr BS Ajaikumar, Chairman and CEO, HCG.

The idea is to measure performance of clinician and institutes and benchmark it with global performance of institutes of repute. Once this is done, the data will be used to improve the existing performance based on the scores. The study will be done both prospectively and retrospectively involving all HCG centers and modalities. The wealth of data resting with HCG that includes predictive analysis, outcomes and even a patient’s response to a particular form of treatment would help to analyse and measure pointers that will offer the best course of treatment for a patient. By means of creating a scorecard for doctors & hospitals, patients will be able to review where HCG stands in comparison with global standards in treating a particular form of cancer, based on its own data and outcome measures. The pilot project will look at some of the endpoints like morbidity, mortality, length-of-stay, hospital acquired infections, hospital re-admission and re-surgery. The study will be published for further learning.

Dr Ajaikumar stressed on the need for generating Indian data to guide policy making. Performance based payment systems will guide the government to analyze schemes like Ayushman Bharat and scientifically calculate treatment costs.

Another area of interest for the study group is to look at precision medicine and genomics. The study will validate the use and protocols for precision medicine in India.

Dr Bhattacharya, has been working with the US Federal government to help implement the Medicare Access and CHIP Reauthorization Act (MACRA) 2015. He has served as the lead Clinical Investigator for a large Acumen Project to assist the Center for Medicare and Medicaid Services to develop a new way to assess the performance of doctors in terms of the appropriateness of medical expenditures. The measures developed in this project will be used in the Medicare Incentive Payment Program (MIPS), which is part of the medicare MACR Act, 2015.

Dr. B. S. Ajaikumar, Chairman & CEO, HealthCare Global Enterprises Limited said, “This is a very important and strategic association for us. It is now time for us to migrate from expensive treatments to a model where cost and outcomes are measured. When we put technology, advances in treatment and talent together, we can achieve global standards of outcome, which defines quality of care. I am sure that with time and enough research on this, we would be the forerunners in India providing cost-effective and outcome-based treatments.”

Speaking on the collaboration with HCG, Dr. Jayanta Bhattacharya M.D., Ph.D., Professor of Medicine, Stanford University said, “India and the US have similar issues in healthcare and it is all about providing treatment that has monetary value to the patient. Enforcing a link between cost and outcome is very important in a low resource environment like India. Data is the right way to go and when analyzed correctly, this data would help us reach the desired outcomes. My goal, along with HCG’s goal is to improve healthcare step by step and I am confident that using lessons learned in the American context and applying it to the Indian scenario, we would be able to positively change the way forward.”

 

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.
Show More

Related Articles

Leave a Reply

Close